{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T07:18:52Z","timestamp":1773472732896,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T00:00:00Z","timestamp":1498608000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s40618-017-0720-0","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T17:35:29Z","timestamp":1498671329000},"page":"203-209","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The effects of alpha-lipoic acid on diabetic myopathy"],"prefix":"10.1007","volume":"41","author":[{"given":"D.","family":"Jurisic-Erzen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Starcevic-Klasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ivanac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Peharec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Girotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Jerkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,28]]},"reference":[{"key":"720_CR1","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813\u2013820. doi: 10.1038\/414813a","journal-title":"Nature"},{"key":"720_CR2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/(SICI)1097-0185(199806)251:2<240::AID-AR13>3.0.CO;2-O","volume":"251","author":"MA Fahim","year":"1998","unstructured":"Fahim MA, El-Sabban F, Davidson N (1998) Muscle contractility decrement and correlated morphology during the pathogenesis of streptozotocin-diabetic mice. Anat Rec 251:240\u2013244","journal-title":"Anat Rec"},{"issue":"4","key":"720_CR3","first-page":"1115","volume":"33","author":"R Jerkovic","year":"2009","unstructured":"Jerkovic R, Bosnar A, Jurisic-Erzen D, Azman J, Starcevic-Klasan G, Peharec S, Coklo M (2009) The effects of long-term experimental diabetes mellitus type 1 on skeletal muscle regeneration capacity. Coll Antropol 33(4):1115\u20131119","journal-title":"Coll Antropol"},{"key":"720_CR4","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s004010100363","volume":"102","author":"K Ozaki","year":"2001","unstructured":"Ozaki K, Matsuura T, Narama I (2001) Histochemical and morphometrical analysis of skeletal muscle in spontaneous diabetic WBN\/Kob rat. Acta Neuropathol 102:264\u2013270","journal-title":"Acta Neuropathol"},{"key":"720_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/ar.1092250107","volume":"225","author":"KM Klueber","year":"1989","unstructured":"Klueber KM, Feczko JD, Schmidt G, Watkins JB 3rd (1989) Skeletal muscle in the diabetic mouse: histochemical and morphometric analysis. Anat Rec 225:41\u201345. doi: 10.1002\/ar.1092250107","journal-title":"Anat Rec"},{"key":"720_CR6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1042\/bj2210645","volume":"221","author":"M Rutschmann","year":"1984","unstructured":"Rutschmann M, Dahlmann B, Reinauer H (1984) Loss of fast-twitch isomyosin in skeletal muscles of the diabetic rat. Biochem J 221:645\u2013650","journal-title":"Biochem J"},{"issue":"1","key":"720_CR7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1247\/csf.22.147","volume":"22","author":"R Jerkovic","year":"1997","unstructured":"Jerkovic R, Argentini C, Serrano-Sanchez A, Cordonnier C, Schiaffino S (1997) Early myosin switching induced by nerve activity in regenerating slow skeletal muscle. Cell Struct Funct 22(1):147\u2013153","journal-title":"Cell Struct Funct"},{"issue":"3","key":"720_CR8","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1046\/j.1365-201X.1998.1630s3S11.x","volume":"163","author":"S Schiaffino","year":"1998","unstructured":"Schiaffino S, Serrano AL, Jerkovic R, Di Lisi R, Murgia M (1998) Neural regulation of myosin gene expression in regenerating skeletal muscle. Acta Physiol Scand 163(3):S11\u2013S15","journal-title":"Acta Physiol Scand"},{"key":"720_CR9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0014-4886(74)90176-9","volume":"43","author":"EC Hall-Craggs","year":"1974","unstructured":"Hall-Craggs EC (1974) Rapid degeneration and regeneration of a whole skeletal muscle following treatment with bupivacaine (Marcain). Exp Neurol 43:349\u2013358","journal-title":"Exp Neurol"},{"key":"720_CR10","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1096\/fasebj.6.14.1426762","volume":"6","author":"RJ Barnard","year":"1992","unstructured":"Barnard RJ, Youngren JF (1992) Regulation of glucose transport in skeletal muscle. FASEB J 6:3238\u20133244","journal-title":"FASEB J"},{"key":"720_CR11","doi-asserted-by":"crossref","first-page":"E994","DOI":"10.1152\/ajpendo.2001.280.6.E994","volume":"280","author":"AE Halseth","year":"2001","unstructured":"Halseth AE, Bracy DP, Wasserman DH (2001) Functional limitations to glucose uptake in muscles comprised of different fiber types. Am J Physiol Endocrinol Metab 280:E994\u2013E999","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"720_CR12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0891-5849(95)00017-R","volume":"19","author":"L Packer","year":"1995","unstructured":"Packer L, Witt EH, Tritschler HJ (1995) alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 19:227\u2013250","journal-title":"Free Radic Biol Med"},{"key":"720_CR13","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s001250050047","volume":"43","author":"K Yaworsky","year":"2000","unstructured":"Yaworsky K, Somwar R, Ramlal T, Tritschler HJ, Klip A (2000) Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3-L1 adipocytes. Diabetologia 43:294\u2013303","journal-title":"Diabetologia"},{"issue":"3","key":"720_CR14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0306-3623(96)00474-0","volume":"29","author":"GP Biewenga","year":"1997","unstructured":"Biewenga GP, Haenen GR, Bast A (1997) The pharmacology of the antioxidant lipoic acid. Gen Pharmacol 29(3):315\u2013331","journal-title":"Gen Pharmacol"},{"issue":"12","key":"720_CR15","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.2337\/diab.45.12.1798","volume":"45","author":"DE Estrada","year":"1996","unstructured":"Estrada DE, Ewart HS, Tsakiridis T, Volchuk A, Ramlal T, Tritschler H, Klip A (1996) Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid\/thioctic acid: participation of elements of the insulin signalling pathway. Diabetes 45(12):1798\u20131804","journal-title":"Diabetes"},{"issue":"7","key":"720_CR16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0026-0495(97)90120-7","volume":"46","author":"M Khamaisi","year":"1999","unstructured":"Khamaisi M, Potashnik R, Tirosh A, Demshchak E, Rudich A, Tritschler H, Wessel K, Bashan N (1999) Lipoic acid reduces glycemia and increases muscle GLUT4 content in streptozotocin-diabetic rats. Metabolism 46(7):763\u2013768","journal-title":"Metabolism"},{"issue":"8","key":"720_CR17","first-page":"872","volume":"45","author":"S Jacob","year":"1995","unstructured":"Jacob S, Henriksen EJ, Schiemann AL, Simon I, Clancy DE, Tritschler HJ, Jung WI, Augustin HJ, Dietze GJ (1995) Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid. Arzneimittelforschung 45(8):872\u2013874","journal-title":"Arzneimittelforschung"},{"issue":"18","key":"720_CR18","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1517\/14656566.2014.972935","volume":"15","author":"N Papanas","year":"2014","unstructured":"Papanas N, Ziegler D (2014) Efficacy of Alpha-lipoic acid in diabetic neuropathy. Expert Opin Pharmacother 15(18):2721\u20132731. doi: 10.1517\/14656566.2014.972935","journal-title":"Expert Opin Pharmacother"},{"issue":"69","key":"720_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2011.00069","volume":"2","author":"S Golbidi","year":"2011","unstructured":"Golbidi S, Badran M, Laher I (2011) Diabetes and alpha lipoic acid. Front Pharmacol 2(69):1\u201315. doi: 10.3389\/fphar.2011.00069","journal-title":"Front Pharmacol"},{"issue":"17","key":"720_CR20","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.4239\/wjd.v6.i17.1323","volume":"6","author":"SK Coleman","year":"2015","unstructured":"Coleman SK, Rebalka IA, D\u2019Souza DM, Hawke TJ (2015) Skeletal muscle as a therapeutic target for delaying type 1 diabetic complications. World J Diabetes 6(17):1323\u20131336. doi: 10.4239\/wjd.v6.i17.1323","journal-title":"World J Diabetes"},{"issue":"5","key":"720_CR21","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1210\/er.2001-0039","volume":"23","author":"JL Evans","year":"2002","unstructured":"Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2002) Oxidative stress and stress-activated signalling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23(5):599\u2013622. doi: 10.1210\/er.2001-0039","journal-title":"Endocr Rev"},{"issue":"6865","key":"720_CR22","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/414799a","volume":"414","author":"AR Saltiel","year":"2001","unstructured":"Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414(6865):799\u2013806. doi: 10.1038\/414799a","journal-title":"Nature"},{"issue":"Suppl 1","key":"720_CR23","first-page":"29","volume":"60","author":"W Wieteska-Skrzeczynska","year":"2009","unstructured":"Wieteska-Skrzeczynska W, Grzelkowska-Kowalczyk K, Jank M, Maciejewski H (2009) Transcriptional dysregulation of skeletal muscle protein metabolism in streptozotocin-diabetic mice. J Physiol Pharmacol 60(Suppl 1):29\u201336","journal-title":"J Physiol Pharmacol"},{"issue":"3","key":"720_CR24","first-page":"163","volume":"26","author":"D Bonnefont-Rousselot","year":"2000","unstructured":"Bonnefont-Rousselot D, Bastard JP, Jaudon MC, Delattre J (2000) Consequences of the diabetic status on the oxidant\/antioxidant balance. Diabetes Metab 26(3):163\u2013176","journal-title":"Diabetes Metab"},{"issue":"5","key":"720_CR25","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.2337\/diacare.26.5.1589","volume":"26","author":"A Cariello","year":"2003","unstructured":"Cariello A (2003) New insights on oxidative stress and diabetic complications may lead to a \u201ccausal\u201d antioxidant therapy. Diabetes Care 26(5):1589\u20131596","journal-title":"Diabetes Care"},{"issue":"8","key":"720_CR26","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.2337\/diacare.22.8.1296","volume":"22","author":"D Ziegler","year":"1999","unstructured":"Ziegler D, Hanefeld M, Ruhnau KJ, Hasche H, Lobisch M, Sch\u00fctte K, Kerum G, Malessa R (1999) Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 22(8):1296\u20131301","journal-title":"Diabetes Care"},{"issue":"1\u20132","key":"720_CR27","first-page":"79","volume":"717","author":"M Panigrahi","year":"1996","unstructured":"Panigrahi M, Sadguna Y, Shivakumar BR, Kolluri SV, Roy S, Packer L, Ravindranath V (1996) Alpha lipoic protects against reperfusion injury following cerebral ischemia in rats. Brain Res 717(1\u20132):79\u2013101","journal-title":"Brain Res"},{"issue":"6","key":"720_CR28","first-page":"308","volume":"13","author":"G Ko\u00e7ak","year":"2000","unstructured":"Ko\u00e7ak G, Aktan F, Canbolat O, Ozo\u011ful C, Elbe\u011f S, Yildizoglu-Ari N, Karasu C, ADIC Study Group-Antioxidants in Diabetes-Induced Complications (2000) Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes. Diabetes Nutr Metab 13(6):308\u2013318","journal-title":"Diabetes Nutr Metab"},{"issue":"6","key":"720_CR29","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.2337\/diabetes.50.6.1464","volume":"50","author":"D Konrad","year":"2001","unstructured":"Konrad D, Somwar R, Sweeney G, Yaworsky K, Hayashi M, Ramlal T, Klip A (2001) The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation. Diabetes 50(6):1464\u20131470","journal-title":"Diabetes"},{"issue":"11","key":"720_CR30","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.2527\/2005.83112611x","volume":"83","author":"QW Shen","year":"2005","unstructured":"Shen QW, Jones CS, Kalchayanand N, Zhu MJ, Du M (2005) Effect of dietary alpha-lipoic acid on growth, body composition, muscle pH, and AMP-activated protein kinase phosphorylation in mice. J Anim Sci 83(11):2611\u20132617","journal-title":"J Anim Sci"},{"issue":"3","key":"720_CR31","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.bbrc.2005.05.035","volume":"332","author":"WJ Lee","year":"2005","unstructured":"Lee WJ, Song KH, Koh EH, Won JC, Kim HS, Park HS, Kim MS, Kim SW, Lee KU, Park JY (2005) Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. Biochem Biophys Res Commun 332(3):885\u2013891. doi: 10.1016\/j.bbrc.2005.05.035","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-017-0720-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-017-0720-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-017-0720-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T03:36:18Z","timestamp":1602387378000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-017-0720-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,28]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["720"],"URL":"https:\/\/doi.org\/10.1007\/s40618-017-0720-0","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,28]]}}}